+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Advanced Urotheilal carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Urotheilal carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
T cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

T cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Advanced Cervical Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 160 Pages
  • Global
From
Advanced Endometrial Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Advanced Renal Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Renal Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Collagen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Collagen inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chronic Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Myeloid Leukemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
TGFb inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TGFb inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD30 Therapies - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD30 Therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD22 Therapies - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD22 Therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TIM-3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TIM-3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2024 - Product Thumbnail Image

Cytidine Deaminase Inhibitors (CDA) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cell wall inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Cell wall inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more